57 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
by the Company. Where the Company has control over an investee, it is classified as a subsidiary. The Company controls an investee if all three of the following … as at September 24, 2019. The CVRs have been classified as a financial liability in the Condensed Consolidated Statement of Financial Position. Given
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
, it is classified as a subsidiary. The Company controls an investee if all three of the following elements are present: power over an investee, exposure or rights … of the acquisition and, accordingly, have been based on fair value as at September 24, 2019. The CVRs have been classified as a financial liability
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
provides otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:58pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b … classified as partnership for U.S. federal income tax purposes or investors therein;
persons who own or are deemed to own, directly or indirectly, 10
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
4:57pm
otherwise, in the case of a corporation whose board of directors is classified, shareholders may effect such removal only for cause, or (b) in the case … . Holders whose functional currency is not the U.S. dollar;
any entity or arrangement classified as partnership for U.S. federal income tax purposes
F-3
06kba
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
83hhs5h
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
09lwa
11 May 22
Prospectus update (post-effective amendment)
5:19pm
6-K
EX-99.2
l9miy0 zur6
11 May 22
Current report (foreign)
4:30pm
424B3
0zvpshajreged254
4 May 22
Prospectus supplement
8:35am
424B3
12e1j c774k
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
4pp9m9asv n9
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
g3k9qc4
9 Mar 22
Prospectus supplement
9:26am
424B3
qnmcfdxr
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
tt1lm xhqhu
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
EX-99.1
ywa149 hpt
25 Feb 22
Current report (foreign)
4:05pm
424B3
oztvkkt
3 Nov 21
Prospectus supplement
7:33am
424B3
a951 c5qf9
3 Nov 21
Prospectus supplement
7:32am